Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Atherosclerosis

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.ATHEROSCLEROSIS.2006.07.024PMID 16942773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics.

  2006cited by this paper
• Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.

  2006cited by this paper
• Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease.

  2006cited by this paper
• HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment.

  2006cited by this paper
• AIDS Res Hum Retroviruses

  2006cited by this paper
• Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection.

  2005cited by this paper
• The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M400489-JLR200

  2005cited by this paper
• Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice.

  2005cited by this paper
• High-density lipoprotein function recent advances.

  2005cited by this paper
• Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine.

  2005cited by this paper
• Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M

  2005cited by this paper
• Paraoxonase 1 activity, concentration and genotype in cardiovascular disease

  2004cited by this paper
• Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.

  2003cited by this paper
• Lipid Rafts and HIV Pathogenesis: Virion-Associated Cholesterol Is Required for Fusion and Infection of Susceptible Cells

  2003cited by this paper
• High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy

  2003cited by this paper
• Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: A gateway to atherosclerosis

  2003cited by this paper
• Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population.

  2003cited by this paper
• Serum paraoxonase activity decreases in rheumatoid arthritis.

  2003cited by this paper
• Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage.

  2002cited by this paper
• Redox Imbalance and Its Control in HIV Infection

  2002cited by this paper
• Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy.

  2001cited by this paper
• Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapy

  2001cited by this paper
• Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

  2001cited by this paper
• Agreement study of methods based on the elimination principle for the measurement of LDL- and HDL-cholesterol compared with ultracentrifugation in patients with liver cirrhosis.

  2000cited by this paper
• Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

  2000cited by this paper
• Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts

  2000cited by this paper
• Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis*

  2000cited by this paper
• Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors

  2000cited by this paper
• Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.

  1999cited by this paper
• Redox and Activation Status of Monocytes from Human Immunodeficiency Virus-Infected Patients: Relationship with Viral Load

  1999cited by this paper
• Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

  1998cited by this paper
• Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

  1998cited by this paper
• The Serum Paraoxonase Activity in Patients with Chronic Renal Failure and Hyperlipidemia

  1998cited by this paper
• Oxidative stress during viral infection: a review.

  1996cited by this paper
• Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

  1995cited by this paper
• Effects of endotoxin on lipid metabolism.

  1995cited by this paper
• Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.

  1995cited by this paper
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

  1993cited by this paper
• Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

  1991cited by this paper
• Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.

  1990cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Effect of Guava Seeds on the Biochemical Parameters and Composition of HDL Subclasses in Ovariectomized Rats

  2025cites this paper
• Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumonia.

  2025cites this paper
• HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?

  2025cites this paper
• PON1 enzyme activity assays for serum and heparinized plasma in horses and stability evaluation of the enzyme activity over different freeze-thaw cycles and mimic transportation.

  2024cites this paper
• Paraoxonase-1: How a xenobiotic detoxifying enzyme has become an actor in the pathophysiology of infectious diseases and cancer.

  2023cites this paper
• Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia

  2022cites this paper
• Paraoxonase 1 rs662 polymorphism, its related variables, and COVID-19 intensity: Considering gender and post-COVID complications

  2022cites this paper
• Microbiota Modulation to Reduce Cardiovascular Risk in HIV Patients: A Systematic Review

  2021cites this paper
• Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach

  2021cites this paper
• On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update

  2021cites this paper
• On the Role of Paraoxonase-1, Chemokine (C-C motif) Ligand 2 and Metabolism in Oxidation, Inflammation and Disease. A 2021 Update

  2021cites this paper
• Prevalence and mortality of COVID-19 are associated with the L55M functional polymorphism of Paraoxonase 1

  2021cites this paper
• Paraoxonase‐1 (PON1) Status Analysis Using Non‐Organophosphate Substrates

  2021cites this paper
• Altered high-density lipoprotein composition and functions during severe COVID-19

  2021cites this paper
• HDL Proteome and Alzheimer’s Disease: Evidence of a Link

  2020cites this paper
• High-Density Lipoproteins Are Bug Scavengers

  2020cites this paper
• Salivary alpha-amylase activity and concentration in horses with acute abdominal disease: Association with outcome.

  2019cites this paper
• Effect of continuous renal-replacement therapy on paraoxonase-1-related variables in patients with acute renal failure caused by septic shock.

  2018cites this paper
• Changes in alpha-amylase activity, concentration and isoforms in pigs after an experimental acute stress model: an exploratory study

  2018cites this paper
• Paraoxonases and infectious diseases.

  2017cites this paper
• Alterations in serum paraoxonase-1 activity and lipid profile in chronic alcoholic patients infected with Strongyloides stercoralis.

  2017cites this paper
• Estudio de la contribución de las células endoteliales progenitoras y las partículas de colesterol HDL en los mecanismos de daño y reparación vascular en pacientes infectados por VIH

  2016cites this paper
• Paraoxonases-1, -2 and -3: What are their functions?

  2016cites this paper
• Distribution of genetic variants of oxidative stress metabolism genes: Paraoxonase 1 (PON1) and Glutathione S-transferase (GSTM1/GSTT1) in a population from Southeastern Mexico

  2016cites this paper
• Serum biomarkers of oxidative stress in cats with feline infectious peritonitis

  2015cites this paper
• HIV infection induces structural and functional changes in high density lipoproteins.

  2015cites this paper
• Autism: What Is It?

  2015cites this paper
• Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials.

  2015cites this paper
• Aktivnost paraoksonaze 1 u premalignim promjenama vrata maternice

  2015influential citation
• Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.

  2015cites this paper
• New Chemiluminescent Substrates of Paraoxonase 1 with Improved Specificity: Synthesis and Properties

  2015cites this paper
• Human Paraoxonase-1 Activity Is Related to the Number of CD4+ T-Cells and Is Restored by Antiretroviral Therapy in HIV-1-Infected Individuals

  2014cites this paper
• Visceral leishmaniasis is associated with marked changes in serum lipid profile

  2014cites this paper
• Study of Paraoxonase -1 Gene Polymorphism in a Healthy Population of Khorramabad, Iran

  2014cites this paper
• TOTAL ANTIOXIDAN LEVEL , TOTAL OXIDAN LEVEL AND SERUM PARAOXONASE-1 LEVELS IN NEONATAL SEPSIS 1 Running title : Paraoxonase-1 in Neonatal Sepsis

  2014cites this paper
• Total antioxidant and total oxidant states, and serum paraoxonase‐1 in neonatal sepsis

  2014cites this paper
• Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

  2013cites this paper
• HDL in HIV-1 infection: a quality perspective through paraoxonase-1 activities

  2013influential citation
• Short communication: Paraoxonase 1 (PON1) in French HIV-infected patients under antiretroviral therapy: relationship with the metabolic syndrome and inflammation.

  2013cites this paper
• Rôle de la Paraoxonase (PON1) dans l'activité anti-inflammatoire de HDL et sa modulation par la diète

  2013cites this paper
• Chapter 34 – Autisms

  2013cites this paper
• Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis.

  2013cites this paper
• Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation[S]

  2012cites this paper
• Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages.

  2012cites this paper
• The Deleterious Influence of Tenofovir-Based Therapies on the Progression of Atherosclerosis in HIV-Infected Patients

  2012cites this paper
• Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis

  2012cites this paper
• Estudo da atividade e polimorfismos da Paraoxonase-1 em indivíduos infectados pelo vírus da imunodeficiência humana tipo-1 (HIV-1) tratados com inibidores de protease

  2012cites this paper
• Serum albumin and paraoxonase activity in Iranian veterans 20 years after sulfur mustard exposure

  2012cites this paper
• HDL-Associated Paraoxonase 1 Gene Polymorphisms as a Genetic Markers for Wide Spread Diseases

  2012cites this paper
• The cardiovascular profile of HIV-infected South Africans of African descent: a 5-year prospective study

  2011cites this paper
• Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.

  2011cites this paper
• Leptospirosis is Associated with Markedly Increased Triglycerides and Small Dense Low-Density Lipoprotein and Decreased High-Density Lipoprotein

  2011cites this paper
• Yenidoğan sepsisinde total antioksidan seviye, total oksidan seviye ve serum paraoksonaz-1 düzeyleri

  2011influential citation
• Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis

  2011cites this paper
• Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.

  2011cites this paper
• Paraoxonase Gene Polymorphism and Chlamydia pneumoniae Infection in Ischemic Vascular Disease.

  2011cites this paper
• Human-Phosphate-Binding-Protein inhibits HIV-1 gene transcription and replication

  2011cites this paper
• Distribution of paraoxonase 1 coding region polymorphisms in Serbian population

  2010cites this paper
• Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes.

  2010cites this paper
• Decreased serum arylesterase activity in autism spectrum disorders.

  2010cites this paper
• Decreased paraoxonase activity in critically ill patients with sepsis

  2010cites this paper
• Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes.

  2010cites this paper
• Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV‐infected patients: relationships with serum markers of oxidation and inflammation

  2010cites this paper
• Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients.

  2010cites this paper
• Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients

  2010cites this paper
• Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity

  2010cites this paper
• The assessment of carotid intima media thickness and serum Paraoxonase-1 activity in Helicobacter pylori positive subjects

  2010cites this paper
• Paraoxonase-1 and its Interactions with HDL

  2010cites this paper
• Persistence of an atherogenic lipid profile after treatment of acute infection with brucella

  2009cites this paper
• Paraoxonases: structure, gene polymorphism & role in coronary artery disease.

  2009cites this paper
• Variation in paraoxonase-1 activity and atherosclerosis

  2009cites this paper
• Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.

  2009cites this paper
• [Physiopathology of cardiovascular disease in HIV-infected patients].

  2009cites this paper
• Monitorização das concentrações plasmáticas de Efavirenz: critérios de aplicabilidade à prática clínica e efeitos do fármaco a longo termo

  2009cites this paper
• The paraoxonases: role in human diseases and methodological difficulties in measurement

  2009cites this paper
• Reelin Gene Polymorphisms in Autistic Disorder

  2008cites this paper
• Paraoxonase-1 in Chronic Liver Diseases, Neurological Diseases and HIV Infection

  2008cites this paper
• Alterations in lipid transfer to high-density lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients.

  2008cites this paper
• THE ROLE OF HUMAN PARAOXONASE 1 (PON-1) IN VIRAL INFECTIONS

  year unknowninfluential citation